Cargando…
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
Small non-functioning pancreatic NETs (pNETs) ≤2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. How...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704448/ https://www.ncbi.nlm.nih.gov/pubmed/29150545 http://dx.doi.org/10.1530/EC-17-0293 |
_version_ | 1783281903108882432 |
---|---|
author | Mills, Logan Drymousis, Panagiotis Vashist, Yogesh Burdelski, Christoph Prachalias, Andreas Srinivasan, Parthi Menon, Krishna Cotoi, Corina Khan, Saboor Cave, Judith Armstrong, Thomas Weickert, Martin O Izbicki, Jakob Schrader, Joerg Frilling, Andreja Ramage, John K Srirajaskanthan, Raj |
author_facet | Mills, Logan Drymousis, Panagiotis Vashist, Yogesh Burdelski, Christoph Prachalias, Andreas Srinivasan, Parthi Menon, Krishna Cotoi, Corina Khan, Saboor Cave, Judith Armstrong, Thomas Weickert, Martin O Izbicki, Jakob Schrader, Joerg Frilling, Andreja Ramage, John K Srirajaskanthan, Raj |
author_sort | Mills, Logan |
collection | PubMed |
description | Small non-functioning pancreatic NETs (pNETs) ≤2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. However, other studies have suggested loco-regional spread can be present in ≤2 cm pNETs. The aim of this study was to characterise the prevalence of malignant features and identify any useful predictive variables in a surgically resected cohort of pNETs. 418 patients with pNETs were identified from 5 NET centres. Of these 227 were included for main analysis of tumour characteristics. Mean age of patients was 57 years, 47% were female. The median follow-up was 48.2 months. Malignant features were identified in 38% of ≤2 cm pNETs. ROC analysis showed that the current cut-off of 20 mm had a sensitivity of 84% for malignancy. The rate of malignant features is in keeping with other surgical series and challenges the belief that small pNETs have a low malignant potential. This study does not support a 20 mm size cut-off as being a solitary safe parameter to exclude malignancy in pNETs. |
format | Online Article Text |
id | pubmed-5704448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-57044482017-12-04 Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours Mills, Logan Drymousis, Panagiotis Vashist, Yogesh Burdelski, Christoph Prachalias, Andreas Srinivasan, Parthi Menon, Krishna Cotoi, Corina Khan, Saboor Cave, Judith Armstrong, Thomas Weickert, Martin O Izbicki, Jakob Schrader, Joerg Frilling, Andreja Ramage, John K Srirajaskanthan, Raj Endocr Connect Research Small non-functioning pancreatic NETs (pNETs) ≤2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. However, other studies have suggested loco-regional spread can be present in ≤2 cm pNETs. The aim of this study was to characterise the prevalence of malignant features and identify any useful predictive variables in a surgically resected cohort of pNETs. 418 patients with pNETs were identified from 5 NET centres. Of these 227 were included for main analysis of tumour characteristics. Mean age of patients was 57 years, 47% were female. The median follow-up was 48.2 months. Malignant features were identified in 38% of ≤2 cm pNETs. ROC analysis showed that the current cut-off of 20 mm had a sensitivity of 84% for malignancy. The rate of malignant features is in keeping with other surgical series and challenges the belief that small pNETs have a low malignant potential. This study does not support a 20 mm size cut-off as being a solitary safe parameter to exclude malignancy in pNETs. Bioscientifica Ltd 2017-10-25 /pmc/articles/PMC5704448/ /pubmed/29150545 http://dx.doi.org/10.1530/EC-17-0293 Text en © 2017 The authors http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Research Mills, Logan Drymousis, Panagiotis Vashist, Yogesh Burdelski, Christoph Prachalias, Andreas Srinivasan, Parthi Menon, Krishna Cotoi, Corina Khan, Saboor Cave, Judith Armstrong, Thomas Weickert, Martin O Izbicki, Jakob Schrader, Joerg Frilling, Andreja Ramage, John K Srirajaskanthan, Raj Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title | Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title_full | Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title_fullStr | Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title_full_unstemmed | Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title_short | Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
title_sort | tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704448/ https://www.ncbi.nlm.nih.gov/pubmed/29150545 http://dx.doi.org/10.1530/EC-17-0293 |
work_keys_str_mv | AT millslogan tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT drymousispanagiotis tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT vashistyogesh tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT burdelskichristoph tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT prachaliasandreas tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT srinivasanparthi tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT menonkrishna tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT cotoicorina tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT khansaboor tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT cavejudith tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT armstrongthomas tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT weickertmartino tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT izbickijakob tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT schraderjoerg tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT frillingandreja tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT ramagejohnk tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours AT srirajaskanthanraj tumourdiameterisnotreliableformanagementofnonsecretingpancreaticneuroendocrinetumours |